These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 2005584)

  • 1. Caffeine potentiates vasodilator-induced renin release.
    Tofovic SP; Branch KR; Oliver RD; Magee WD; Jackson EK
    J Pharmacol Exp Ther; 1991 Mar; 256(3):850-60. PubMed ID: 2005584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of endogenous adenosine as a modulator of the renin response to salt restriction.
    Kuan CJ; Wells JN; Jackson EK
    Nephrologie; 1987; 8(6):283-6. PubMed ID: 3330576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous adenosine restrains renin release during sodium restriction.
    Kuan CJ; Wells JN; Jackson EK
    J Pharmacol Exp Ther; 1989 Apr; 249(1):110-6. PubMed ID: 2651649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of adenosine blockade on plasma renin activity and catecholamines.
    Tung CS; Kuan CJ; Tarng JL; Tseng CJ
    Proc Natl Sci Counc Repub China B; 1993 Jan; 17(1):21-8. PubMed ID: 8234540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine-angiotensin II interactions. Part II. The role of adenosine in regulating angiotensin II-induced changes in heart rate and aldosterone release.
    Holycross BJ; Li P; Jackson EK
    J Pharmacol Exp Ther; 1989 Aug; 250(2):442-53. PubMed ID: 2760838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeine potentiates the renin response to furosemide in rats. Evidence for a regulatory role of endogenous adenosine.
    Paul S; Jackson EK; Robertson D; Branch RA; Biaggioni I
    J Pharmacol Exp Ther; 1989 Oct; 251(1):183-7. PubMed ID: 2677316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous adenosine restrains renin release in conscious rats.
    Kuan CJ; Wells JN; Jackson EK
    Circ Res; 1990 Mar; 66(3):637-46. PubMed ID: 2407369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central effects of caffeine on renal renin secretion and norepinephrine spillover.
    Tofovic SP; Kusaka H; Pfeifer CA; Jackson EK
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):302-13. PubMed ID: 8856488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of adenosine in noradrenergic neurotransmission during hemorrhagic hypotension.
    Jackson EK; Herzer WA; Kuan CJ
    J Pharmacol Exp Ther; 1994 Aug; 270(2):589-94. PubMed ID: 8071851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered renin release and propranolol potentiation of vasodilatory drug hypotension.
    Pettinger WA; Keeton K
    J Clin Invest; 1975 Feb; 55(2):236-43. PubMed ID: 236325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine potentiates the renin response to diazoxide in man. Evidence for a regulatory role of endogenous adenosine.
    Brown NJ; Porter J; Ryder D; Branch RA
    J Pharmacol Exp Ther; 1991 Jan; 256(1):56-61. PubMed ID: 1988669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of the cardiovascular effects of adenosine by caffeine or 8-(p-sulfophenyl)theophylline.
    Evoniuk G; von Borstel RW; Wurtman RJ
    J Pharmacol Exp Ther; 1987 Feb; 240(2):428-32. PubMed ID: 3806407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in sympathetic neurotransmission and adrenergic control of cardiac contractility during 1,3-dipropyl-8-sulfophenylxanthine-induced hypertension.
    Rubino A; Burnstock G
    J Pharmacol Exp Ther; 1995 Oct; 275(1):422-8. PubMed ID: 7562580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine-angiotensin II interactions. Part I. Role of adenosine in regulating angiotensin II-induced potentiation of noradrenergic neurotransmission and angiotensin II-induced vasoconstriction.
    Holycross BJ; Jackson EK
    J Pharmacol Exp Ther; 1989 Aug; 250(2):433-41. PubMed ID: 2547930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylxanthines augment the renin response to suprarenal-aortic constriction.
    Deray G; Branch RA; Jackson EK
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):690-6. PubMed ID: 2570368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of adenosine agonists in the conscious spontaneously hypertensive rat.
    Webb RL; McNeal RB; Barclay BW; Yasay GD
    J Pharmacol Exp Ther; 1990 Sep; 254(3):1090-9. PubMed ID: 2203898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of adenosine deaminase attenuates endotoxin-induced release of cytokines in vivo in rats.
    Tofovic SP; Zacharia L; Carcillo JA; Jackson EK
    Shock; 2001 Sep; 16(3):196-202. PubMed ID: 11531021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of superoxide and hydrogen peroxide in hypertension induced by an antagonist of adenosine receptors.
    Sousa T; Pinho D; Morato M; Marques-Lopes J; Fernandes E; Afonso J; Oliveira S; Carvalho F; Albino-Teixeira A
    Eur J Pharmacol; 2008 Jul; 588(2-3):267-76. PubMed ID: 18519134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.
    Zolk O; Flesch M; Schnabel P; Teisman AC; Pinto YM; van Gilst WH; Paul M; Böhm M
    Br J Pharmacol; 1998 Feb; 123(3):405-12. PubMed ID: 9504380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of a simple behavioral response mediated selectively by central adenosine A1 receptors, using in vivo and in vitro techniques.
    Marston HM; Finlayson K; Maemoto T; Olverman HJ; Akahane A; Sharkey J; Butcher SP
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1023-30. PubMed ID: 9618404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.